Nuzenio

Tonix Pharmaceuticals Announces

Tonix Pharmaceuticals Announces news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Timeline

Mon, 10 Aug 2026 12:41:49 GMTTonix Pharmaceuticals (NASDAQ:TNXP) Announces Earnings Results - MarketBeat
Thu, 06 Aug 2026 20:52:45 GMTTonix Pharmaceuticals Holding Corp. (TNXP) stock price, news, quote and history - Yahoo Finance Australia
Wed, 05 Aug 2026 11:00:00 GMTTonix CEO Seth Lederman to Take Part in Two Investor Events - Stock Titan
Mon, 03 Aug 2026 16:23:39 GMTTonix Pharmaceuticals receives Type C meeting minutes from FDA for TNX-4800 - TipRanks
Mon, 03 Aug 2026 11:23:01 GMTTonix Pharmaceuticals Announces FDA Alignment on 3,300‑Participant Adaptive Phase 2 Lyme Study; TNX-4800 Dosing, 2027 Site Delivery - TradingView
Mon, 03 Aug 2026 11:15:00 GMTTonix Pharmaceuticals Announces FDA Alignment on Phase 2 Study Design for TNX-4800 Lyme Disease Prevention Trial - Quiver Quantitative

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tonix Pharmaceuticals Announces.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.